Impax Pharma Resubmits RYTARY Extended-Release Capsules to FDA By: Benzinga via Benzinga April 11, 2014 at 07:17 AM EDT Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug ... Read More >>